Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

Motus GI (MOTS) Competitors

Motus GI logo
Compare

MOTS vs. AFIB, UTRS, DRTSW, ANZUW, and HSCSW

Should you buy Motus GI stock or one of its competitors? MarketBeat compares Motus GI with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Motus GI include Acutus Medical (AFIB), Minerva Surgical (UTRS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry.

How does Motus GI compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Motus GI Neutral

Motus GI has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Motus GI's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Motus GI N/A N/A N/A

Motus GI has lower revenue, but higher earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Motus GI$319K0.00-$12.87M-$14.69N/A

56.9% of Acutus Medical shares are owned by institutional investors. Comparatively, 20.1% of Motus GI shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Comparatively, 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Acutus Medical has a beta of 6.08, suggesting that its stock price is 508% more volatile than the broader market. Comparatively, Motus GI has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

Summary

Acutus Medical and Motus GI tied by winning 5 of the 10 factors compared between the two stocks.

How does Motus GI compare to Minerva Surgical?

Minerva Surgical (NASDAQ:UTRS) and Motus GI (NASDAQ:MOTS) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings and media sentiment.

Minerva Surgical has a beta of 2.92, suggesting that its share price is 192% more volatile than the broader market. Comparatively, Motus GI has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market.

Motus GI has lower revenue, but higher earnings than Minerva Surgical. Minerva Surgical is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Motus GI$319K0.00-$12.87M-$14.69N/A

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Motus GI Neutral

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Motus GI N/A N/A N/A

20.1% of Motus GI shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by company insiders. Comparatively, 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Motus GI compare to Alpha Tau Medical?

Motus GI (NASDAQ:MOTS) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, earnings, media sentiment, risk, dividends and valuation.

20.1% of Motus GI shares are owned by institutional investors. 0.3% of Motus GI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Alpha Tau Medical had 1 more articles in the media than Motus GI. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for Motus GI. Motus GI's average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Alpha Tau Medical Neutral

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

Alpha Tau Medical has lower revenue, but higher earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

Motus GI beats Alpha Tau Medical on 3 of the 4 factors compared between the two stocks.

How does Motus GI compare to Anzu Special Acquisition Corp I?

Motus GI (NASDAQ:MOTS) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Anzu Special Acquisition Corp I'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Anzu Special Acquisition Corp I Neutral

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

Summary

Motus GI beats Anzu Special Acquisition Corp I on 3 of the 3 factors compared between the two stocks.

How does Motus GI compare to Heart Test Laboratories?

Motus GI (NASDAQ:MOTS) and Heart Test Laboratories (NASDAQ:HSCSW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

Heart Test Laboratories has lower revenue, but higher earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Heart Test Laboratories$8.67KN/AN/AN/AN/A

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Heart Test Laboratories'average media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Heart Test Laboratories Neutral

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Heart Test Laboratories N/A N/A N/A

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Motus GI beats Heart Test Laboratories on 3 of the 3 factors compared between the two stocks.

Get Motus GI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOTS vs. The Competition

Export
MetricMotus GISurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$47.45M$6.27B$12.27B
Dividend YieldN/A1.08%2.80%5.32%
P/E Ratio0.0017.8120.8525.19
Price / SalesN/A33.51511.6861.11
Price / CashN/A18.8743.0954.25
Price / BookN/A14.879.906.95
Net Income-$12.87M-$20.48M$3.55B$335.25M

Motus GI Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
AFIB
Acutus Medical
N/A$0.00
-66.7%		N/A-99.7%$3K$7.16MN/A340
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
DRTSW
Alpha Tau Medical
N/A$1.80
+2.3%		N/A+1,168.9%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.07
flat		N/A+7.6%$0.00N/AN/A2

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:MOTS) was last updated on 5/20/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Are we ignoring the same signal Wall Street ignored in 1929?
In 1929, Irving Weiss spotted a systemic crisis hiding beneath record highs and shorted the market - turning $...
Weiss Ratings | Sponsoredtc pixel
The Death of the Nasdaq?
The Death of the Nasdaq? Wall Street legend Marc Chaikin's award-winning system turned bearish on software ...
Chaikin Analytics | Sponsoredtc pixel
What Netscape taught us about the next big infrastructure play
SpaceX doesn't function without autonomous flight systems, AI navigation, semiconductor chips, and real-time d...
True Market Insiders | Sponsoredtc pixel
Trump Is Eyeing the Biggest Monetary Shift Since Nixon
On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...
Americas Gold Company | Sponsoredtc pixel